▶ 29:19 · $INBRAIN-NEUROELECTRONICS · Health Expert: "AI already knows more than your doctor" - SeedRocket Roundtable

episode briefing

Health Expert: "AI already knows more than your doctor" - SeedRocket Roundtable

2026-06-10 · 8 company · 10 thematic

sentiment

5 bull1 bear2 neu

speakers

Practitioner of the forward-deployed engineer model. Described how his team of 50 deployment engineers (growing to 75-100) acts as problem-solvers for enterprise clients, becoming the best sales channel.

yolanda pérez

Leads health tech investing for V Startup, Banco Sabadell's corporate venture arm, which has invested in ~23 health companies since 2017 across therapeutics, devices, digital health, and diagnostics; focuses on Spanish science spinouts needing early capital.

jesús monleón

Host of SeedRocket's 4Founders podcast; runs Go Trendier (a secondhand fashion marketplace) and 4Founders; actively applies AI learnings from guests to his own companies.

quote

“Inbrain va a competir es mucho mejor que Neuralink. Neuralink es la empresa de Elon Mask, ¿no? Eh, que entonces es como Neurolink, pero en esteroides con mucha más resolución, vamos a decirlo así. Igual me mata por decir aquí y sabiendo a…”

—yolanda pérez

now playing · $INBRAIN-NEUROELECTRONICS

$INBRAIN-NEUROELECTRONICSbullish· high· posyolanda pérez

Graphene brain implants outperform Neuralink with human clinical validation

Inbrain's graphene-based neurostimulation devices achieve higher resolution than Neuralink, have already been implanted in humans for Parkinson's and epilepsy, and are led by ex-M…

$BFLY···bullish· high· pospablo

Handheld ultrasound IPO delivered strong returns despite interpretation bottleneck

Butterfly's phone-connected ultrasound democratizes imaging access for remote areas, and the fund realized a very good return at IPO; however, the remaining challenge is AI-assist…

$BB-SCRIPTSbearish· medium· pospablo

Maternity digital health point solution fails to scale for venture returns

After 9 years and several million in revenue, BB Scripts cannot scale beyond a ceiling, illustrating why point solutions in digital health generate insufficient IRR for venture po…

$VIRTA-HEALTHbullish· high· pospablo

Diabetes reversal platform positioned as pre-GLP-1 employer benefit heading to IPO

Virta's employer-paid program reverses type 2 diabetes without insulin, reducing costly complications; now positioned as a mandatory step before GLP-1 coverage, creating a massive…

$HIMS···bullish· mediumpablo

Integrated telehealth-pharmacy-marketing machine targeting multi-billion valuation

Hims & Hers operates a three-layer flywheel — teleconsultation, owned pharmacy fulfillment, and performance marketing — enabling end-to-end control of high-volume conditions like…

$KIDAbullish· medium· posjesús monleón

Home care platform becoming European category leader with €60M raised

Kida's trained caregiver marketplace has achieved product-market fit in Spain, attracting specialized health funds and Sabadell, and is profiling as the European winner in tech-en…

$COLUMBUS-VENTURE-PARTNERSneutral· lowpablo

Specialized fund with deep mRNA manufacturing expertise backing Viralgen exit

Columbus understands the mRNA production supply chain and backed Viralgen's €4B exit; their operational knowledge in manufacturing infrastructure makes them a key partner for hard…

$ADMIT-THERAPEUTICSneutral· medium· pospablo

Blood test predicts Alzheimer's and progression to dementia via beta-amyloid markers

Admit's blood-based assay detects beta-amyloid presence and predicts Alzheimer's progression to dementia, but commercial viability hinges on actionability — currently limited by l…

←